About
Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, engages in the manufacture and sale of pharmaceutical products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, and BIB sweet tablets. The company was incorporated in 1989 and is based in Bulandshahr, India.
Key Metrics
as of Sep 2026Market Cap66 Cr
P/E—
Div Yield0.00 %
Book Value₹18.20
52w High₹22.60
52w Low₹14.10
Face Value₹10.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 7.65 | 0.00 | 26.48 | 10.48 | 22.04 | 17.43 | 24.70 | 14.22 | 15.62 | 25.20 | 25.36 |
| Expenses | 4.68 | 4.31 | 11.67 | 4.72 | 28.98 | 15.31 | 25.71 | 16.41 | 28.19 | 13.18 | 31.54 | 27.47 | 29.86 |
| Operating Profit | -4.68 | -4.31 | -4.02 | -4.72 | -2.50 | -4.83 | -3.67 | 1.02 | -3.49 | 1.04 | -15.92 | -2.27 | -4.50 |
| OPM % | — | — | -52.55 | — | -9.44 | -46.09 | -16.65 | 5.85 | -14.13 | 7.31 | -101.92 | -9.01 | -17.74 |
| Other Income | 0.16 | 0.10 | 0.49 | 0.10 | 0.32 | 0.14 | 0.59 | 0.12 | 0.22 | 0.25 | 9.08 | 1.20 | 0.14 |
| Depreciation | 0.03 | 0.03 | 0.09 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Interest | 2.09 | 1.72 | 2.06 | 1.67 | 1.74 | 1.58 | 1.68 | 1.54 | 1.23 | 1.16 | 1.22 | 1.30 | 1.17 |
| Profit before tax | -6.64 | -5.96 | -5.68 | -6.33 | -3.96 | -6.31 | -4.81 | -0.44 | -4.56 | 0.07 | -8.12 | -2.43 | -5.59 |
| Tax % | -26.05 | -23.15 | -31.69 | -26.07 | -22.22 | -20.76 | -11.02 | -25.00 | 105.26 | -2,642.86 | -19.46 | -21.81 | -30.77 |
| Net Profit | -4.92 | -4.59 | -3.88 | -4.68 | -3.08 | -5.00 | -4.28 | -0.33 | -9.36 | 1.93 | -6.53 | -1.89 | -3.87 |
| EPS in Rs | -1.14 | -1.06 | -0.90 | -1.08 | -0.71 | -1.16 | -0.99 | -0.08 | -2.17 | 0.45 | -1.51 | -0.44 | -0.90 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 45.00 | 78.00 | 85.00 | 67.00 | 84.00 | 35.00 | 124.00 | 128.00 | 146.00 | 203.00 | 173.00 | 46.00 |
| Expenses | 63.00 | 83.00 | 106.00 | 77.00 | 93.00 | 43.00 | 111.00 | 132.00 | 143.00 | 191.00 | 164.00 | 41.00 |
| Operating Profit | -18.00 | -5.00 | -21.00 | -10.00 | -9.00 | -8.00 | 13.00 | -4.00 | 3.00 | 12.00 | 9.00 | 6.00 |
| OPM % | -41.00 | -6.00 | -24.00 | -16.00 | -11.00 | -23.00 | 10.00 | -3.10 | 2.30 | 6.00 | 5.00 | 12.00 |
| Other Income | 3.00 | 1.00 | 2.00 | 1.00 | 4.00 | 1.00 | 1.00 | 1.00 | 1.00 | 6.00 | 1.00 | 2.00 |
| Interest | 7.00 | 6.00 | 5.00 | 5.00 | 2.00 | 1.00 | 4.00 | 6.00 | 1.00 | 6.00 | 2.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Profit before tax | -23.00 | -10.00 | -24.00 | -14.00 | -7.00 | -8.00 | 9.00 | -9.00 | 2.00 | 11.00 | 7.00 | 6.00 |
| Tax % | -25.00 | -10.00 | -25.00 | -28.00 | -21.00 | -46.00 | 29.00 | -31.00 | 26.00 | 42.00 | 27.00 | -111.00 |
| Net Profit | -17.00 | -9.00 | -18.00 | -10.00 | -6.00 | -4.00 | 7.00 | -6.00 | 2.00 | 6.00 | 5.00 | 13.00 |
| EPS in Rs | -3.95 | -2.03 | -4.19 | -2.36 | -1.34 | -0.99 | 1.51 | -1.44 | 0.36 | 1.48 | 1.16 | 2.91 |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Sep 2023 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 | 43.00 |
| Reserves | 36.00 | 45.00 | 62.00 | -9.00 | -23.00 | -12.00 | -6.00 | -1.00 | -8.00 | -2.00 | -3.00 | -1.00 | -15.00 |
| Borrowings | 74.00 | 70.00 | 78.00 | 27.00 | 3.00 | 32.00 | 0.00 | 0.00 | 9.00 | -9.00 | -1.00 | 0.00 | 7.00 |
| Other Liabilities | 35.00 | 28.00 | 29.00 | 43.00 | 103.00 | 62.00 | 16.00 | 17.00 | 24.00 | 48.00 | 52.00 | 48.00 | 45.00 |
| Total Liabilities | 188.00 | 186.00 | 213.00 | 104.00 | 127.00 | 125.00 | 53.00 | 59.00 | 68.00 | 80.00 | 91.00 | 90.00 | 81.00 |
| Fixed Assets | 115.00 | 115.00 | 116.00 | 4.00 | 4.00 | 5.00 | 5.00 | 5.00 | 6.00 | 6.00 | 7.00 | 8.00 | 9.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 32.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 73.00 | 70.00 | 97.00 | 68.00 | 122.00 | 120.00 | 48.00 | 53.00 | 63.00 | 74.00 | 84.00 | 82.00 | 71.00 |
| Total Assets | 188.00 | 186.00 | 213.00 | 104.00 | 127.00 | 125.00 | 53.00 | 59.00 | 68.00 | 80.00 | 91.00 | 90.00 | 81.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 11.00 | -42.00 | 12.00 | 34.00 | -32.00 | 3.00 | -17.00 | -9.00 | 8.00 | -12.00 | 31.00 | 5.00 |
| Cash from Investing Activity | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | -1.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from Financing Activity | -15.00 | 45.00 | -12.00 | -34.00 | 31.00 | -1.00 | -3.00 | -2.00 | -1.00 | -6.00 | 0.00 | -3.00 |
| Net Cash Flow | -3.00 | 3.00 | 0.00 | 1.00 | -1.00 | 1.00 | -20.00 | -10.00 | 7.00 | -18.00 | 31.00 | 2.00 |
| Free Cash Flow | 11.00 | -42.00 | 12.00 | 34.00 | -32.00 | 3.00 | -17.00 | -9.00 | 8.00 | -12.00 | 32.00 | 5.00 |
| CFO/OP % | -59.00 | 847.00 | -56.00 | -328.00 | 344.00 | -32.00 | -132.00 | 239.00 | 229.00 | -99.00 | 338.00 | 89.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 114.00 | 5.00 | 0.00 | 96.00 | 318.00 | 167.00 | 19.00 | 37.00 | 34.00 | 47.00 | 2.00 | 209.00 |
| Inventory Days | 13.00 | 202.00 | 56.00 | 308.00 | 67.00 | 23.00 | 2.00 | 77.00 | 84.00 | 66.00 | 87.00 | 241.00 |
| Days Payable | 4.00 | 5.00 | 61.00 | 259.00 | 204.00 | 6.00 | 1.00 | 26.00 | 103.00 | 70.00 | 99.00 | 316.00 |
| Cash Conversion Cycle | 122.00 | 203.00 | -5.00 | 145.00 | 181.00 | 185.00 | 19.00 | 88.00 | 16.00 | 43.00 | -9.00 | 134.00 |
| Working Capital Days | -549.00 | -227.00 | -174.00 | -108.00 | 10.00 | 59.00 | -19.00 | 28.00 | 20.00 | 21.00 | -20.00 | -20.00 |
| ROCE % | -9.00 | -3.00 | -46.00 | -22.00 | -11.00 | -18.00 | 31.00 | -8.00 | 9.00 | 42.00 | 23.00 | 20.00 |
Corporate Actions
No corporate actions recorded.